Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor

Abstract

OBJECTIVES This retrospective study used various indices to evaluate remission and low disease activity in 'real life' patients with rheumatoid arthritis (RA), given antitumour necrosis factor (anti-TNF) as a first-line treatment; changes in concomitant steroid and conventional synthetic disease-modifying antirheumatic drug (csDMARD) treatment were also… (More)

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Conigliaro2016RemissionAL, title={Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor}, author={Paola Conigliaro and Maria Sole Chimenti and Paola Triggianese and Eleonora Ballanti and Flavia Sunzini and Iaria Duca and Roberto Perricone}, booktitle={The Journal of international medical research}, year={2016} }